• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    New insider Madryn Asset Management, Lp claimed ownership of 6,363,636 shares (SEC Form 3)

    1/11/24 9:45:02 PM ET
    $GBNH
    Misc Health and Biotechnology Services
    Health Care
    Get the next $GBNH alert in real time by email
    SEC FORM 3 SEC Form 3
    FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0104
    Estimated average burden
    hours per response: 0.5
    1. Name and Address of Reporting Person*
    Madryn Asset Management, LP

    (Last) (First) (Middle)
    330 MADISON AVENUE - FLOOR 33

    (Street)
    NEW YORK NY 10017

    (City) (State) (Zip)
    2. Date of Event Requiring Statement (Month/Day/Year)
    01/01/2024
    3. Issuer Name and Ticker or Trading Symbol
    Greenbrook TMS Inc. [ GBNH ]
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    Form filed by One Reporting Person
    X Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Common Stock 6,363,636 I See footnotes(1)(2)(3)
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date Exercisable Expiration Date Title Amount or Number of Shares
    Common Share Conversion Instruments(4) 07/14/2022 09/30/2027 Common Stock 3,910,604 $1.9 I See footnotes(1)(2)(5)
    Subordinated Convertible Notes(6) 08/15/2023 03/31/2028 Common Stock 13,837,637 $0.2168(7)(8) I See footnotes(1)(2)(9)
    Subordinated Convertible Notes(6) 10/12/2023 03/31/2028 Common Stock 6,479,481 $0.2315(7)(10) I See footnotes(1)(2)(11)
    1. Name and Address of Reporting Person*
    Madryn Asset Management, LP

    (Last) (First) (Middle)
    330 MADISON AVENUE - FLOOR 33

    (Street)
    NEW YORK NY 10017

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    Madryn Health Partners, LP

    (Last) (First) (Middle)
    330 MADISON AVENUE - FLOOR 33

    (Street)
    NEW YORK NY 10017

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP

    (Last) (First) (Middle)
    330 MADISON AVENUE - FLOOR 33

    (Street)
    NEW YORK NY 10017

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    Madryn Select Opportunities, LP

    (Last) (First) (Middle)
    330 MADISON AVENUE - FLOOR 33

    (Street)
    NEW YORK NY 10017

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    MADRYN HEALTH ADVISORS II, LP

    (Last) (First) (Middle)
    330 MADISON AVENUE - FLOOR 33

    (Street)
    NEW YORK NY 10017

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    MADRYN HEALTH ADVISORS GP II, LLC

    (Last) (First) (Middle)
    330 MADISON AVENUE - FLOOR 33

    (Street)
    NEW YORK NY 10017

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    MADRYN SELECT ADVISORS, LP

    (Last) (First) (Middle)
    330 MADISON AVENUE - FLOOR 33

    (Street)
    NEW YORK NY 10017

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    MADRYN SELECT ADVISORS GP, LLC

    (Last) (First) (Middle)
    330 MADISON AVENUE - FLOOR 33

    (Street)
    NEW YORK NY 10017

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    Explanation of Responses:
    1. Represents securities held directly by Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and, in the case of the Common Share Conversion Instruments described in Table II, Madryn Select Opportunities, LP ("Select Opportunities" and together with Health Partners and Cayman Master, the "Funds"). Madryn Asset Management, LP ("Madryn"), as investment advisor for each of the Funds, and each of Madryn Health Advisors II, LP, Madryn Health Advisors GP II, LLC, Madryn Select Advisors, LP, and Madryn Select Advisors GP, LLC, as general partners for each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds.
    2. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein.
    3. Health Partners and Cayman Master directly hold 393,459 and 5,970,177 shares of the Company's common stock ("Common Shares"), respectively.
    4. Each of the Funds entered into a common share conversion instrument on July 14, 2022 (collectively, as amended and/or restated from time to time, the "Conversion Instruments") in connection with loans provided under the Company's senior secured credit facility with Madryn and its affiliates.
    5. Health Partners, Cayman Master, and Select Opportunities may receive (a) 202,423, (b) 3,071,480 and (c) 636,701 Common Shares, respectively, upon the exercise of the Conversion Instruments.
    6. On each of August 15, 2023, September 1, 2023, and October 12, 2023, Health Partners and Cayman Master acquired from the Company subordinated convertible promissory notes (the "Subordinated Convertible Notes").
    7. The Subordinated Convertible Notes are convertible at a price equal to the lesser of (a) 85% of the closing price per Common Shares on Nasdaq or any other market as of the closing date for such Subordinated Convertible Notes and (b)(i) 85% of the 30-day volume weighted average trading price of the Common Shares prior to conversion, or (ii) if the Common Shares are not listed on any of Nasdaq or another trading market at the time of conversion, a per share price based equal to 85% of the fair market value per Common Share as of such date; provided, that, in any event, the Subordinated Convertible Note conversion price shall not be lower than $0.078. The conversion price of the Subordinated Convertible Notes is also subject to customary anti-dilution adjustments
    8. The conversion price of the Subordinated Convertible Notes issued on each of August 15, 2023 and September 1, 2023 is $0.2168.
    9. With respect to the Subordinated Convertible Notes issued on August 15, 2023 and September 1, 2023, Health Partners and Cayman Master may convert such Subordinated Convertible Notes into an aggregate of 855,571 and 12,982,066 Common Shares, respectively.
    10. The conversion price of the Subordinated Convertible Notes issued on October 12, 2023 is $0.2315.
    11. With respect to the Subordinated Convertible Notes issued on October 12, 2023, Health Partners and Cayman Master may convert such Subordinated Convertible Notes into an aggregate of 400,622 and 6,078,859 Common Shares, respectively.
    Madryn Asset Management, LP, By: /s/ Matthew Girandola, Name: Matthew Girandola, Title: Authorized Signatory 01/11/2024
    Madryn Health Partners II, LP, By: /s/ Matthew Girandola, Name: Matthew Girandola, Title: Authorized Signatory 01/11/2024
    Madryn Health Partners II (Cayman Master), LP, By: /s/ Matthew Girandola, Name: Matthew Girandola, Title: Authorized Signatory 01/11/2024
    Madryn Select Opportunities, LP, By: /s/ Matthew Girandola, Name: Matthew Girandola, Title: Authorized Signatory 01/11/2024
    Madryn Health Advisors II, LP, By: /s/ Matthew Girandola, Name: Matthew Girandola, Title: Authorized Signatory 01/11/2024
    Madryn Health Advisors GP II, LLC, By: /s/ Matthew Girandola, Name: Matthew Girandola, Title: Authorized Signatory 01/11/2024
    Madryn Select Advisors, LP, By: /s/ Matthew Girandola, Name: Matthew Girandola, Title: Authorized Signatory 01/11/2024
    Madryn Select Advisors GP, LLC, By: /s/ Matthew Girandola, Name: Matthew Girandola, Title: Authorized Signatory 01/11/2024
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $GBNH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GBNH

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $GBNH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Greybrook Announces Passing of Founder Elias Vamvakas

      TORONTO, July 11, 2024 /CNW/ - It is with heavy hearts that the Executive Team at Greybrook announces the passing of our cherished founder, Elias Vamvakas, today, after a courageous battle with pancreatic cancer. Elias was 65 years old. Elias Vamvakas was a visionary leader whose entrepreneurial spirit and dedication laid the foundation for Greybrook, a distinguished Canadian private equity firm with investments in real estate and health care. Born in 1958 in Athens, Greece, Elias immigrated to Canada in 1966. His journey from an immigrant to a celebrated business leader was a

      7/11/24 1:55:00 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • GREENBROOK TMS ANNOUNCES DELISTING FROM NASDAQ

      TORONTO, Feb. 23, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced receipt of the final delisting notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") due to the continued failure to satisfy either the $1.00 minimum bid price listing requirement in Nasdaq Listing Rule 5550(a)(2) or the minimum stockholders' equity requirements in Nasdaq Listing Rule 5550(b). Nasdaq has notified the Company that trading of its common shares (the "Common Shares") will be suspended as of the open of trading on February 26, 2024. After careful consideration, the Company determined that it was in the overall best interests

      2/23/24 9:00:00 AM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • Greenbrook Announces $1.2 Million Registered Direct Offering

      TORONTO, Feb. 22, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company"), today announced that it has entered into securities purchase agreements with  institutional investors for the purchase and sale of 6,000,000 common shares at a purchase price of $0.20 per share pursuant to a registered direct offering, resulting in gross proceeds of approximately $1.2 million before deducting placement agent commissions and other estimated offering expenses. The closing of the offering is expected to occur on or about February 26, 2024, subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds for working capital as well as

      2/22/24 8:00:00 AM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care

    $GBNH
    Financials

    Live finance-specific insights

    See more
    • GREENBROOK TMS ANNOUNCES DELISTING FROM NASDAQ

      TORONTO, Feb. 23, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced receipt of the final delisting notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") due to the continued failure to satisfy either the $1.00 minimum bid price listing requirement in Nasdaq Listing Rule 5550(a)(2) or the minimum stockholders' equity requirements in Nasdaq Listing Rule 5550(b). Nasdaq has notified the Company that trading of its common shares (the "Common Shares") will be suspended as of the open of trading on February 26, 2024. After careful consideration, the Company determined that it was in the overall best interests

      2/23/24 9:00:00 AM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • GREENBROOK TMS RAISES US$2.5 MILLION IN DEBT FINANCING

      TORONTO, Feb. 15, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced that it has entered into the twenty-fifth amendment (the "Amendment") to the Company's credit facility (the "Credit Facility") with affiliates of Madryn Asset Management, LP ("Madryn"). As part of the Amendment, the Company secured an additional US$2,538,071 in senior secured term loans from Madryn under the Credit Facility (the "New Loan"). After giving effect to the New Loan, the Company has an aggregate amount of approximately US$87 million outstanding under the Credit Facility. The proceeds of the New Loan are expected to be used by the Company for general corporate an

      2/15/24 5:21:00 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • GREENBROOK TMS RAISES US$1.5 MILLION IN DEBT FINANCING

      TORONTO, Feb. 6, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced that it has entered into the twenty-fourth amendment (the "Amendment") to the Company's credit facility (the "Credit Facility") with affiliates of Madryn Asset Management, LP ("Madryn"). As part of the Amendment, the Company secured an additional US$1,522,843 in senior secured term loans from Madryn under the Credit Facility (the "New Loan"). After giving effect to the New Loan, the Company has an aggregate amount of approximately US$85 million outstanding under the Credit Facility. The proceeds of the New Loan are expected to be used by the Company for general corporate an

      2/6/24 5:15:00 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care

    $GBNH
    SEC Filings

    See more
    • Greenbrook TMS Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

      8-K - Greenbrook TMS Inc. (0001735948) (Filer)

      3/15/24 3:46:21 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • Greenbrook TMS Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Greenbrook TMS Inc. (0001735948) (Filer)

      3/8/24 3:19:54 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • Greenbrook TMS Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

      8-K - Greenbrook TMS Inc. (0001735948) (Filer)

      3/1/24 4:58:50 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care

    $GBNH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Crish Andrew

      3 - Greenbrook TMS Inc. (0001735948) (Issuer)

      3/8/24 4:51:46 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form 3 filed by new insider Elstad Juliana

      3 - Greenbrook TMS Inc. (0001735948) (Issuer)

      2/2/24 4:31:30 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • New insider Madryn Asset Management, Lp claimed ownership of 6,363,636 shares (SEC Form 3)

      3 - Greenbrook TMS Inc. (0001735948) (Issuer)

      1/11/24 9:45:02 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care

    $GBNH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by Greenbrook TMS Inc. (Amendment)

      SC 13D/A - Greenbrook TMS Inc. (0001735948) (Subject)

      2/28/24 5:22:33 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form SC 13D/A filed by Greenbrook TMS Inc. (Amendment)

      SC 13D/A - Greenbrook TMS Inc. (0001735948) (Subject)

      2/28/24 3:26:24 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form SC 13D/A filed by Greenbrook TMS Inc. (Amendment)

      SC 13D/A - Greenbrook TMS Inc. (0001735948) (Subject)

      10/24/23 4:15:27 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care

    $GBNH
    Leadership Updates

    Live Leadership Updates

    See more
    • GREENBROOK APPOINTS PETER WILLETT AS CHIEF FINANCIAL OFFICER

      TORONTO, Jan. 29, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced that the Company's Board of Directors has appointed Mr. Peter Willett as the Company's full-time Chief Financial Officer, effective immediately. Mr. Willett was appointed Interim Chief Financial Officer of the Company in October 2023, prior to which he has been a key player on the Greenbrook finance team over the past six years, serving as its Senior Vice President of Finance. Peter brings over 11 years of finance experience, providing a broad base of experience and specialized knowledge about the financial and accounting matters that are unique to the mental health servic

      1/29/24 5:00:00 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • GREENBROOK TMS ANNOUNCES DIRECTOR APPOINTMENT

      TORONTO, Jan. 23, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced that it has appointed Ms. Juliana Elstad to the Company's board of directors as an independent director, effective immediately. Ms. Elstad has also been appointed to the Company's Governance and Nominating Committee. Juliana Elstad is a CEO, entrepreneur, and advisor with over 20 years of experience bringing medical innovation to patients and delivering success in small startup to multi-billion-dollar environments. She has a proven track record of creating, growing, and leading medical technology organizations with a focus on building dynamic cultures and mentoring high-po

      1/23/24 4:31:00 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • GREENBROOK TMS ANNOUNCES RESULTS OF VOTING AT ANNUAL MEETING OF SHAREHOLDERS

      TORONTO, June 20, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company"), a leading provider of Transcranial Magnetic Stimulation ("TMS") therapy in the United States, announced today the results of voting at its annual meeting of shareholders held earlier today (the "Meeting"). Each of the matters voted upon at the Meeting as set out below is described in greater detail in the Notice of Annual Meeting of Shareholders and Management Information Circular of Greenbrook dated May 11, 2023 (the "Circular").   The total number of common shares represented at the Meeting was 29,769,721, representing approximately 72.96% of Greenbrook's outstanding common shares entit

      6/20/23 5:00:00 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care